Literature DB >> 1366628

Characterization and novel purification of recombinant human protein C from three mammalian cell lines.

S C Yan1, P Razzano, Y B Chao, J D Walls, D T Berg, D B McClure, B W Grinnell.   

Abstract

Human Protein C (HPC), an antithrombotic factor with potential clinical utility, is a vitamin K-dependent protein that has several complex post-translational modifications. In an effort to define the functional roles of these modifications, recombinant HPC (rHPC) was expressed in and characterized from 3 adenovirus-transformed cell lines. The rHPC in crude culture medium from the 3 cell lines displayed anticoagulant activities that were either higher, slightly lower or much lower than that of plasma HPC. The rHPC from each cell line was purified and characterized using a novel, but simple chromatographic method, termed "pseudo-affinity", capable of resolving molecules differing by only very slight modifications. We demonstrate the critical dependence of full gamma-carboxylation on the function of this protein. In addition, our data indicate that both the gamma-carboxyglutamate and glycosyl contents affect the functional activities of rHPC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1366628     DOI: 10.1038/nbt0790-655

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  27 in total

1.  E1a-responsive mammalian host/vector system for the stable high-level expression of secreted proteins.

Authors:  D T Berg; D B McClure; B W Grinnell
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

2.  Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.

Authors:  J Y Chang; D M Monroe; D W Stafford; K M Brinkhous; H R Roberts
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines.

Authors:  M I Cockett; C R Bebbington; G T Yarranton
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

4.  Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity.

Authors:  Yaoming Wang; Meenakshisundaram Thiyagarajan; Nienwen Chow; Itender Singh; Huang Guo; Thomas P Davis; Berislav V Zlokovic
Journal:  Stroke       Date:  2008-12-04       Impact factor: 7.914

5.  Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells.

Authors:  Fionnuala Ní Ainle; James S O'Donnell; Jennifer A Johnson; Laura Brown; Eimear M Gleeson; Owen P Smith; Roger J S Preston
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

6.  Functional Study of the Vitamin K Cycle Enzymes in Live Cells.

Authors:  J-K Tie; D W Stafford
Journal:  Methods Enzymol       Date:  2016-11-22       Impact factor: 1.600

7.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

8.  Insights into vitamin K-dependent carboxylation: home field advantage.

Authors:  Francis Ayombil; Rodney M Camire
Journal:  Haematologica       Date:  2020-08       Impact factor: 9.941

9.  Functional study of the vitamin K cycle in mammalian cells.

Authors:  Jian-Ke Tie; Da-Yun Jin; David L Straight; Darrel W Stafford
Journal:  Blood       Date:  2011-01-14       Impact factor: 22.113

10.  High mobility group protein, HMG-1, contains insignificant glycosyl modification.

Authors:  Y B Chao; W M Scovell; S B Yan
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.